SII’s Covovax vaccine

The Subject Expert Committee of India`s apex drugs authority Drugs Controller General of India (DCGI) has recommended permission for vaccine manufacturer Serum Institute of India to conducting Phase 3 trial of Covovax as booster dose in…
Read More...